These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 8691835

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
    Huber K, Kirchheimer JC, Sedlmayer A, Bell C, Ermler D, Binder BR.
    Cancer Res; 1993 Apr 15; 53(8):1788-93. PubMed ID: 8467497
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW, Jiang B, Han CZ, Jing JX.
    Zhonghua Zhong Liu Za Zhi; 2005 May 15; 27(5):286-8. PubMed ID: 15996321
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
    Forones NM, Tanaka M.
    Hepatogastroenterology; 1999 May 15; 46(26):905-8. PubMed ID: 10370636
    [Abstract] [Full Text] [Related]

  • 30. [Standards, options and recommendations for tumor markers in colorectal cancer].
    Eche N, Pichon MF, Quillien V, Gory-Delabaere G, Riedinger JM, Basuyau JP, Daver A, Buecher B, Conroy T, Dieu L, Bidart JM, Deneux L, Groupe de travail Nicole Eche (coordonnateur), oncobiologiste.
    Bull Cancer; 2001 Dec 15; 88(12):1177-206. PubMed ID: 11792611
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
    Sandelewski A, Kokocińska D, Partyka R, Kocot J, Starzewski J, Chanek I, Jałowiecki P.
    Pol Merkur Lekarski; 2005 Jun 15; 18(108):647-50. PubMed ID: 16124375
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G, Müller-Ruchholtz W.
    Cancer Detect Prev; 2001 Jun 15; 25(4):344-51. PubMed ID: 11531011
    [Abstract] [Full Text] [Related]

  • 35. Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.
    Lindmark G, Kressner U, Bergström R, Glimelius B.
    Anticancer Res; 1996 Jun 15; 16(2):895-8. PubMed ID: 8687147
    [Abstract] [Full Text] [Related]

  • 36. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 Jun 15; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z, Skwarek A, Chrzanowska A, Mielczarek M, Nyckowski P, Barańczyk-Kuźma A.
    Pol Merkur Lekarski; 2004 Jan 15; 16(91):31-3. PubMed ID: 15074017
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.